mhurhangee/ep-ind-claims huggingface dataset:
A fluorine-containing macroinitiator comprising: a polymer represented by the following formula and having a number-average molecular weight of 3,000 to 100,000, wherein R 2 is a straight-chain alkyl group of 1 to 18 carbon atoms, R 3 and R 4 are each independently a hydrogen atom or an alkyl group of 1 to 3 carbon atoms, and any one of R 3 and R 4 may contain one carboxyl group, and Q is a polymer segment composed of a structural unit represented by the following formula: wherein R 1 is a hydrogen atom or a methyl group, Rf is a fluoroalkyl group represented by the following formula, and k is an appropriate integer that is not 0, wherein a is an integer of 0 to 3, b is an integer of 1 to 2, n' is an integer of 1 to 6, -C n' F 2n'+1 group is bonded to CH 2 group of-(CF 2 CH 2) b - group, and -(CF 2 CF 2) a - group is bonded to CF 2 group of -(CF 2 CH 2) b - group. a polymer represented by the following formula and having a number-average molecular weight of 3,000 to 100,000, wherein R 2 is a straight-chain alkyl group of 1 to 18 carbon atoms, R 3 and R 4 are each independently a hydrogen atom or an alkyl group of 1 to 3 carbon atoms, and any one of R 3 and R 4 may contain one carboxyl group, and Q is a polymer segment composed of a structural unit represented by the following formula: wherein R 1 is a hydrogen atom or a methyl group, Rf is a fluoroalkyl group represented by the following formula, and k is an appropriate integer that is not 0, wherein a is an integer of 0 to 3, b is an integer of 1 to 2, n' is an integer of 1 to 6, -C n' F 2n'+1 group is bonded to CH 2 group of-(CF 2 CH 2) b - group, and -(CF 2 CF 2) a - group is bonded to CF 2 group of -(CF 2 CH 2) b - group.
A carbon nanotube dispersion liquid comprising: carbon nanotubes; a polymeric dispersant including a sulfonic acid group-containing monomeric unit and an ethylenically unsaturated aliphatic carboxylic acid monomeric unit; and a solvent, wherein percentage content of the ethylenically unsaturated aliphatic carboxylic acid monomeric unit in the polymeric dispersant is greater than 20 mol% and no greater than 90 mol%, and wherein the number-average molecular weight of the polymeric dispersant is at least 1,000,000. carbon nanotubes; a polymeric dispersant including a sulfonic acid group-containing monomeric unit and an ethylenically unsaturated aliphatic carboxylic acid monomeric unit; and a solvent, wherein percentage content of the ethylenically unsaturated aliphatic carboxylic acid monomeric unit in the polymeric dispersant is greater than 20 mol% and no greater than 90 mol%, and wherein the number-average molecular weight of the polymeric dispersant is at least 1,000,000.
A spacing assembly, comprising: a support body comprising a first guide track (400, 402, 202) that extends in a spacing direction between a first end and a second end; a moveable body received in the first guide track (400, 402, 202, 424), wherein the first guide track (400, 402, 202, 424) allows movement of the moveable body in the spacing direction and provides a lateral restriction to movement of the moveable body in a lateral direction perpendicular to the spacing direction; and an adjuster comprising a first spiral channel and a second spiral channel arranged about a common point on a surface of the adjuster; wherein the support body comprises a first lug that is received within the first spiral channel and the moveable body comprises a second lug that is received within the second spiral channel, such that the adjuster is rotatable about the common point by sliding the first spiral channel and the second spiral channel on the first lug and second lug, respectively; wherein the first spiral channel and the second spiral channel extend radially outwards in a curve of increasing radius from the common point, such that rotation of the adjuster will force the first lug and the second lug to move to different radial positions from the common point, thereby driving the adjuster and the moveable body, under the lateral restriction of the first guide track (400, 402, 202, 424), to move relative to the support body in the spacing direction. a support body comprising a first guide track (400, 402, 202) that extends in a spacing direction between a first end and a second end; a moveable body received in the first guide track (400, 402, 202, 424), wherein the first guide track (400, 402, 202, 424) allows movement of the moveable body in the spacing direction and provides a lateral restriction to movement of the moveable body in a lateral direction perpendicular to the spacing direction; and an adjuster comprising a first spiral channel and a second spiral channel arranged about a common point on a surface of the adjuster; wherein the support body comprises a first lug that is received within the first spiral channel and the moveable body comprises a second lug that is received within the second spiral channel, such that the adjuster is rotatable about the common point by sliding the first spiral channel and the second spiral channel on the first lug and second lug, respectively; wherein the first spiral channel and the second spiral channel extend radially outwards in a curve of increasing radius from the common point, such that rotation of the adjuster will force the first lug and the second lug to move to different radial positions from the common point, thereby driving the adjuster and the moveable body, under the lateral restriction of the first guide track (400, 402, 202, 424), to move relative to the support body in the spacing direction.
A guidewire (1; 2; 3; 4) comprising: a core shaft; a coil body that covers the core shaft; and a coating portion (10; 12; 14; 16) that covers the coil body, wherein the coating portion (10; 12; 14; 16) is formed by stacking a plurality of films (10a, 10b; 12a, 12b, 12c; 14a, 14b, 14c; 16a, 16b, 16c), and a lowermost layer film (10a; 12a; 14a; 16a) of the coating portion (10; 12; 14; 16) is arranged to come between wires of the coil body, characterized in that a void (20; 22a; 24a; 26) is formed between a portion in which the lowermost layer film (10a; 12a; 14a; 16a) is arranged to come between the wires of the coil body and a film (10b, 12c; 14c; 16c) disposed above the lowermost layer film (10a; 12a; 14a; 16). a core shaft; a coil body that covers the core shaft; and a coating portion (10; 12; 14; 16) that covers the coil body, wherein the coating portion (10; 12; 14; 16) is formed by stacking a plurality of films (10a, 10b; 12a, 12b, 12c; 14a, 14b, 14c; 16a, 16b, 16c), and a lowermost layer film (10a; 12a; 14a; 16a) of the coating portion (10; 12; 14; 16) is arranged to come between wires of the coil body, characterized in that a void (20; 22a; 24a; 26) is formed between a portion in which the lowermost layer film (10a; 12a; 14a; 16a) is arranged to come between the wires of the coil body and a film (10b, 12c; 14c; 16c) disposed above the lowermost layer film (10a; 12a; 14a; 16).
A prosthetic valve for implanting at a native mitral or tricuspid valve region of the heart, the native valve region having a native valve annulus and native leaflets, the prosthetic valve being configured to be radially crimped into a collapsed configuration within a sheath of a delivery catheter and comprising: a frame comprising: a tubular or annular main body covered by a skirt; an atrial cap extending from an inflow end of the main body; and a plurality of ventricular anchors extending from an outflow end of the main body; and a valve structure comprising a plurality of leaflets; wherein: the main body has a double-body structure, including an annular outer portion overlapping an annular inner portion; the atrial cap is integral with the outer portion of the main body; the ventricular anchors extend from the inner portion of the main body; one or more of the individual ventricular anchors have a variable thickness along their length; and the inner and outer portions of the main body are attached to each other for example by welding, using interlocking tabs, using suture or wire, and/or with pins. a frame comprising: a tubular or annular main body covered by a skirt; an atrial cap extending from an inflow end of the main body; and a plurality of ventricular anchors extending from an outflow end of the main body; and a tubular or annular main body covered by a skirt; an atrial cap extending from an inflow end of the main body; and a plurality of ventricular anchors extending from an outflow end of the main body; and a valve structure comprising a plurality of leaflets; wherein: the main body has a double-body structure, including an annular outer portion overlapping an annular inner portion; the atrial cap is integral with the outer portion of the main body; the ventricular anchors extend from the inner portion of the main body; one or more of the individual ventricular anchors have a variable thickness along their length; and the inner and outer portions of the main body are attached to each other for example by welding, using interlocking tabs, using suture or wire, and/or with pins. the main body has a double-body structure, including an annular outer portion overlapping an annular inner portion; the atrial cap is integral with the outer portion of the main body; the ventricular anchors extend from the inner portion of the main body; one or more of the individual ventricular anchors have a variable thickness along their length; and the inner and outer portions of the main body are attached to each other for example by welding, using interlocking tabs, using suture or wire, and/or with pins.
Oral multiparticulate pharmaceutical form comprising pellets having an average diameter in the range from 50 to 2500 μm, which are composed essentially of a) an inner matrix layer comprising nanoparticles which comprise a nucleic acid active ingredient, and are embedded into a matrix of a polymer having a mucoadhesive effect, where the matrix may optionally comprise further pharmaceutically usual excipients, b) an outer film coating consisting essentially of an anionic polymer or copolymer which may optionally be formulated with pharmaceutically usual excipients, especially plasticizers, characterized in that the multiparticulate pharmaceutical form is formulated so that the contained pellets are released in the pH range of the stomach, the outer coating is adjusted through the choice of the anionic polymer or copolymer and its formulation with excipients and its layer thickness so that the coating dissolves in pH ranges from 4.0 to 8.0 in the intestine within 15 to 60 min so that the active ingredient-containing, mucoadhesive matrix layer is exposed and can bind to the intestinal mucosa and release the active ingredient there, where the polymer having a mucoadhesive effect is chosen so that it exhibits a mucoadhesive effect of at least η b = 150 to 1000 mPa·s and a water uptake of from 10 to 750% in 15 min in a range of +/- 0.5 pH units relative to the pH at which the outer coating starts to dissolve, and the active ingredient content of the nanoparticles in the matrix layer is a maximum of 40% by weight of the content of polymers having a mucoadhesive effect. a) an inner matrix layer comprising nanoparticles which comprise a nucleic acid active ingredient, and are embedded into a matrix of a polymer having a mucoadhesive effect, where the matrix may optionally comprise further pharmaceutically usual excipients, b) an outer film coating consisting essentially of an anionic polymer or copolymer which may optionally be formulated with pharmaceutically usual excipients, especially plasticizers, characterized in that
A simulator (40; 200) for simulating a sensing system, comprising: a plurality of modules operable to simulate one or more sensors sensing a scene (104; 204), the plurality of modules comprising: a path modeling module (116; 216) operable to model a path for each sensor of the one or more sensors; a radiative transfer module (118; 218) operable to model a transfer of radiance from the scene to each sensor of the one or more sensors; one or more instrument response modules operable to model the response of the one or more sensors to the transferred radiance; and a control module (72; 172) operable to manage the operation of the plurality of modules, characterised by: a product evaluation module (154; 254) operable to: receive one or more geophysical products determined in accordance with the response of the one or more sensors; compare the geophysical products with the scene (104; 204); and evaluate the one or more sensors in accordance with the comparison. a plurality of modules operable to simulate one or more sensors sensing a scene (104; 204), the plurality of modules comprising: a path modeling module (116; 216) operable to model a path for each sensor of the one or more sensors; a radiative transfer module (118; 218) operable to model a transfer of radiance from the scene to each sensor of the one or more sensors; one or more instrument response modules operable to model the response of the one or more sensors to the transferred radiance; and a control module (72; 172) operable to manage the operation of the plurality of modules, characterised by: a product evaluation module (154; 254) operable to: receive one or more geophysical products determined in accordance with the response of the one or more sensors; compare the geophysical products with the scene (104; 204); and evaluate the one or more sensors in accordance with the comparison. a path modeling module (116; 216) operable to model a path for each sensor of the one or more sensors; a radiative transfer module (118; 218) operable to model a transfer of radiance from the scene to each sensor of the one or more sensors; one or more instrument response modules operable to model the response of the one or more sensors to the transferred radiance; and a control module (72; 172) operable to manage the operation of the plurality of modules, characterised by: a product evaluation module (154; 254) operable to: receive one or more geophysical products determined in accordance with the response of the one or more sensors; compare the geophysical products with the scene (104; 204); and evaluate the one or more sensors in accordance with the comparison. a product evaluation module (154; 254) operable to: receive one or more geophysical products determined in accordance with the response of the one or more sensors; compare the geophysical products with the scene (104; 204); and evaluate the one or more sensors in accordance with the comparison. receive one or more geophysical products determined in accordance with the response of the one or more sensors; compare the geophysical products with the scene (104; 204); and evaluate the one or more sensors in accordance with the comparison.
A method for isolating a hematopoietic stem cell from adipose tissue-comprising: preparing a stromal vascular fraction from an isolated adipose tissue; incubating SVF cells in a stromal cell media in a cell culture apparatus for a time suitable for the culture of cells in vitro to allow the adherent cells to adhere to the culture apparatus; and isolating nonadherent cells from the stromal cell media, wherein the nonadherent cells comprise a hematopoietic stem cell, further comprising isolating a CD34+ cell and/or an ALDH br cell and/or an ABCG2-expressing cell from the nonadherent cells. preparing a stromal vascular fraction from an isolated adipose tissue; incubating SVF cells in a stromal cell media in a cell culture apparatus for a time suitable for the culture of cells in vitro to allow the adherent cells to adhere to the culture apparatus; and isolating nonadherent cells from the stromal cell media, wherein the nonadherent cells comprise a hematopoietic stem cell, further comprising isolating a CD34+ cell and/or an ALDH br cell and/or an ABCG2-expressing cell from the nonadherent cells.
A method of preparing a personal care composition, wherein the composition comprises: a cationic surfactant system comprising a mono-alkyl amine salt cationic surfactant and a di-alkyl cationic surfactant; a high melting point fatty compound having a melting point of 25°C or higher; and an aqueous carrier, wherein the mono-alkyl amine salt cationic surfactant is a salt of a tertiary amido amine having an alkyl group of from 12 to 22 carbon atoms; and an acid which is selected from the group consisting of L-glutamic acid, lactic acid, hydrochloric acid, malic acid, succinic acid, acetic acid, fumaric acid, tartaric acid, citric acid, L-glutamic hydrochloride, maleic acid, and mixtures thereof, at a molar ratio of the amine to the acid of from 1:0.3 to 1:2; wherein the di-alkyl cationic surfactant is a di-alkyl quaternized ammonium salt having the following formula: wherein two of R 71, R 72, R 73 and R 74 are selected from an alkyl group of from 12 to 30 carbon atoms; and the remainder of R 71, R 72, R 73 and R 74 are independently selected from CH 3, C 2 H 5, C 2 H 4 OH, CH 2 C 6 H 5, and mixture thereof; and X - is a salt-forming anion selected from the group consisting of halides such as chloride and bromide, C 1 -C 4 alkyl sulfate such as methosulfate and ethosulfate, and mixtures thereof; wherein the method comprises the steps: preparing an oil phase comprising the surfactant and the high melting point fatty compound, wherein the temperature of the oil phase is higher than a melting point of the high melting point fatty compound; and preparing an aqueous phase comprising the aqueous carrier, wherein the temperature of the aqueous phase is below the melting point of the high melting point fatty compound; and mixing the oil phase and the aqueous phase to form an emulsion; wherein the mixing step comprises the following detailed steps: feeding either of the oil phase or the aqueous phase into a high shear field having an energy density of 1.0x10 2 J/m 3 or more; feeding the other phase directly to the field; and forming an emulsion; wherein the mixing step is conducted by using a homogenizer having a rotating member; wherein the oil phase contains from 0 to 50% of the aqueous carrier by weight of the oil phase; wherein the composition further comprises a soluble salt; wherein the soluble salt has a solubility in water at 25°C of 0.5g/100g water or more; and wherein the weight ratio of the soluble salt to the acid for the mono-alkyl amine salt cationic surfactant is from 1:0.5 to 1:10. preparing an oil phase comprising the surfactant and the high melting point fatty compound, wherein the temperature of the oil phase is higher than a melting point of the high melting point fatty compound; and preparing an aqueous phase comprising the aqueous carrier, wherein the temperature of the aqueous phase is below the melting point of the high melting point fatty compound; and mixing the oil phase and the aqueous phase to form an emulsion; feeding either of the oil phase or the aqueous phase into a high shear field having an energy density of 1.0x10 2 J/m 3 or more; feeding the other phase directly to the field; and forming an emulsion;
A profile connector (5.1, 5.2, 6.1, 6.2) comprising at least - one first connecting arm which may be inserted into a profile (3, 4) and - one second connecting arm which may be inserted into a profile (3, 4), wherein - a rotational joint having at least one axis of rotation (9, 10) is configured between the first connecting arm and the second connecting arm, such that the first connecting arm and the second connecting arm are able to be transferred by a relative pivoting movement about the at least one axis of rotation (9, 10) of the rotational joint from a starting position into an assembly position in which the first connecting arm and the second connecting arm are arranged in one plane at a right angle to one another, characterised in that - the first connecting arm has a first receiving channel and the second connecting arm has a second receiving channel, wherein the first receiving channel and the second receiving channel are arranged so as to be aligned with one another in the assembly position, and - a separate fixing element is provided, wherein the fixing element may be inserted into the first receiving channel and into the second receiving channel in the assembly position, such that the first connecting arm and the second connecting arm are secured against a relative movement. - one first connecting arm which may be inserted into a profile (3, 4) and - one second connecting arm which may be inserted into a profile (3, 4), wherein - a rotational joint having at least one axis of rotation (9, 10) is configured between the first connecting arm and the second connecting arm, such that the first connecting arm and the second connecting arm are able to be transferred by a relative pivoting movement about the at least one axis of rotation (9, 10) of the rotational joint from a starting position into an assembly position in which the first connecting arm and the second connecting arm are arranged in one plane at a right angle to one another, characterised in that - the first connecting arm has a first receiving channel and the second connecting arm has a second receiving channel, wherein the first receiving channel and the second receiving channel are arranged so as to be aligned with one another in the assembly position, and - a separate fixing element is provided, wherein the fixing element may be inserted into the first receiving channel and into the second receiving channel in the assembly position, such that the first connecting arm and the second connecting arm are secured against a relative movement.
A gel composition consisting of: 1.5% w/v of carboxymethyl cellulose; 20% of 99.7% glycerol; and a 2.7% solution of yeast beta glucan in purified water to 100%, wherein the beta glucan is derived from Saccharomyces cerevisiae and comprises a backbone of β-(1,3)-linked glucosyl residues and side chains comprising 2 or more β-(1,3)-linked glucosyl residues, the sidechains being attached to the backbone via a β-(1,6)-linkage, and wherein said beta glucan is essentially free of repetitive β(1,6) linked glucosyl residues, wherein said composition has a gel to sol melting point above 37°C, and wherein said gel composition is prepared by: i) dissolving said carboxymethyl cellulose in said 2.7% solution of yeast beta glucan while stirring; ii) adding said glycerol; iii) sterilizing in an autoclave at 120°C for 18 minutes; and iv) cooling until the temperature reaches 40°C within 50 to 60 minutes. 1.5% w/v of carboxymethyl cellulose; 20% of 99.7% glycerol; and a 2.7% solution of yeast beta glucan in purified water to 100%, i) dissolving said carboxymethyl cellulose in said 2.7% solution of yeast beta glucan while stirring; ii) adding said glycerol; iii) sterilizing in an autoclave at 120°C for 18 minutes; and iv) cooling until the temperature reaches 40°C within 50 to 60 minutes.